Home » Resources » Clinical Data Repository
SARC has established a vast repository of clinical data sets which includes essential clinical trial data acquired over the years from our researchers and collaborators. This data is now available to sarcoma researchers for further study.
The SARC Clinical Data Repository inventory includes data sets from 12 clinical trials, including more than 1,700 patients with various subtypes of sarcoma.
SARC001 Phase II Trial of Imatinib Mesylate in Bone and Soft Tissue Sarcoma
SARC002 Phase III Trial of Gemcitabine v. Gemcitabine Plus Docetaxel in Soft Tissue Sarcoma
SARC003 Phase II Trial of Gemcitabine and Docetaxel in Osteosarcoma, Ewing sarcoma, Chondrosarcoma
SARC004 Phase II Trial of Gemcitabine and Docetaxel in Uterine Leiomyosarcoma
SARC005 Phase II Trial of Adriamycin/ifosfamide and Adriamycin/etoposide in MPNST
SARC006 Phase II Trial of Adriamycin/ifosfamide and Adriamycin/etoposide in MPNST
SARC007 Phase II Trial of Perifosine in Chemo-Insensitive Sarcomas
SARC009 Phase II Trial of Dasatinib in Advanced Sarcomas
SARC016 Phase II Trial of Everolimus With Bevacizumab in MPNST
SARC018 – SPORE 01 Phase II Trial of Mocetinostat and Gemcitabine in Metastatic Leiomyosarcoma
SARC020 Phase II/III Trial of Doxorubicin Hydrochloride or Trabectedin in Metastatic Soft Tissue Sarcoma
SARC021 Phase III Trial of TH-302 with or without Doxorubicin in Soft Tissue Sarcoma
SARC028 Phase II Study of the Anti-PD1 Antibody Pembrolizumab (MK-3475) in Patients with Advanced Sarcomas
Have an idea for a study that calls for SARC clinical data? We’d like to know about it. Please contact us at sarc-uds@sarctrials.org for details on using our data.
Applications to use SARC Clinical Data Sets may be submitted at any time. Request access by completing the Data Access Application Form and submit completed form to sarc-uds@sarctrials.org. Processing fees are included on the last page of the application form.